Clinical Trial Update: Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

View source ↗

Summary

A completed observational trial in HIV-infected children examining outcomes on a protease inhibitor– and reverse transcriptase inhibitor–based regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Protease inhibitors
• Reverse Transcriptase Inhibitors

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infection | Status: COMPLETED